Paper
Nocistatin inhibits 5‐hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways
Published Oct 1, 2007 · M. Fantin, C. Fischetti, C. Trapella
British Journal of Pharmacology
21
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Study Snapshot
Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex through activation of G(i/o) protein linked pathways, without involving classical opioid receptors and the NOP receptor.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···